SRI-011381 hydrochloride

TargetMol
Product Code: TAR-T5129
Supplier: TargetMol
CodeSizePrice
TAR-T5129-2mg2mg£102.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5129-5mg5mg£122.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5129-1mL1 mL * 10 mM (in DMSO)£127.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5129-10mg10mg£161.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5129-25mg25mg£262.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5129-50mg50mg£389.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5129-100mg100mg£544.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5129-500mg500mg£1,099.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.
CAS:
2070014-88-7
Formula:
C20H32ClN3O
Molecular Weight:
365.95
Pathway:
Stem Cells
Purity:
0.9959
SMILES:
Cl.O=C(NC1CCCCC1)N(CC1CCNCC1)Cc1ccccc1
Target:
TGF-beta/Smad

References

Benzyl urea derivatives for activating tgf-beta signaling. US 20160039756 A1. 2016. Feb Yao Z, Zhang F, Qi C, et al.SECTM1 promotes the development of glioblastoma and mesenchymal transition by regulating the TGF?1/Smad signaling pathway.International Journal of Biological Sciences.2024, 20(1): 78-93.